Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Optimal Duration of Dual Antiplatelet Therapy After Stent-assisted Coiling of Unruptured Intracranial Aneurysms
NCT05257824Phase 4Completed
- Sponsor
- Seoul National University Bundang Hospital
- Start
- Jun 2022
- Primary completion
- Dec 2025
- Modality
- Orthosteric Ligands
- Countries
- 1
01
Overview
Phase 4, randomised, open-label trial of aspirin and clopidogrel in brain aneurysm (IA) (2 arms), sponsored by Seoul National University Bundang Hospital. Primary endpoint: Incidence of thromboembolic complications. Started Jun 2022; status: completed.
02
Drugs
aspirinclopidogrel
03
Conditions
brain aneurysm (IA)
Beyond the preview
Go deeper on NCT05257824.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT05257824.